These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN. Am J Ophthalmol; 2004 Sep; 138(3 Suppl):S19-31. PubMed ID: 15364049 [Abstract] [Full Text] [Related]
3. Evolving global risk assessment of ocular hypertension to glaucoma. Fechtner RD, Khouri AS. Curr Opin Ophthalmol; 2007 Mar; 18(2):104-9. PubMed ID: 17301610 [Abstract] [Full Text] [Related]
4. A revisit: ocular hypertension, glaucoma suspect, preglaucoma, or glaucoma? Shields MB. Ann Ophthalmol; 1985 Aug; 17(8):456. PubMed ID: 4051376 [No Abstract] [Full Text] [Related]
11. Risk assessment in glaucoma and ocular hypertension. Medeiros FA, Weinreb RN. Int Ophthalmol Clin; 2008 Jun; 48(4):1-12. PubMed ID: 18936633 [No Abstract] [Full Text] [Related]
12. Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study. Chandrasekaran S, Cumming RG, Rochtchina E, Mitchell P. Ophthalmology; 2006 Mar; 113(3):417-24. PubMed ID: 16458969 [Abstract] [Full Text] [Related]
13. Risk of glaucoma in ocular hypertension with and without pseudoexfoliation. Grødum K, Heijl A, Bengtsson B. Ophthalmology; 2005 Mar; 112(3):386-90. PubMed ID: 15745763 [Abstract] [Full Text] [Related]
18. Ocular hypertension and secondary glaucoma in children with uveitis. Sijssens KM, Rothova A, Berendschot TT, de Boer JH. Ophthalmology; 2006 May; 113(5):853-9.e2. PubMed ID: 16650683 [Abstract] [Full Text] [Related]